Uricaemia as a surrogate endpoint in gout trials and the treat-to-target approach for gout management

被引：1
|
作者：
Bardin, Thomas [1 ,2 ]
Richette, Pascal [3 ,4 ]
机构：
[1] Univ Paris, INSERM, U1132, F-75010 Paris, France
[2] Inst Mutualiste Montsouris, Dept Med, Paris, France
[3] Hop Lariboisiere, APHP Paris Nord, Dept Rheumatol, Paris, France
[4] Univ Paris, INSERM, U1132, Paris, France
来源：
LANCET RHEUMATOLOGY | 2022年 / 4卷 / 01期
关键词：
D O I：
10.1016/S2665-9913(21)00358-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：E7 / E8
页数：2
相关论文
共 50 条
  • [41] Two-year reduction of dual-energy CT urate depositions during a treat-to-target strategy in gout in the NOR-Gout longitudinal study
    Uhlig, Till
    Eskild, Tron
    Karoliussen, Lars F.
    Sexton, Joe
    Kvien, Tore K.
    Haavardsholm, Espen A.
    Dalbeth, Nicola
    Hammer, Hilde Berner
    RHEUMATOLOGY, 2022, 61 (SI) : SI81 - SI85
  • [42] IMAGING IN THE MANAGEMENT OF GOUT. CLINICAL TOOL OR ENDPOINT?
    Dalbeth, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 20 - 20
  • [43] Comparative Safety of Gout "Treat-to-target" and "Usual Care" Treatment Strategies on Cardiovascular Outcomes Using Observational Data: Causal Inference Approach
    Yoshida, Kazuki
    Liu, Jun
    Solomon, Daniel
    Glynn, Robert J.
    Kim, Seoyoung
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 4095 - 4098
  • [44] Treat-to-target urate-lowering therapy and hospitalizations for gout: results from a nationwide cohort study in England
    Russell, Mark D.
    Roddy, Edward
    Rutherford, Andrew, I
    Ellis, Benjamin
    Norton, Sam
    Douiri, Abdel
    Gulliford, Martin C.
    Cope, Andrew P.
    Galloway, James B.
    RHEUMATOLOGY, 2023, 62 (07) : 2426 - 2434
  • [45] Toward a treat-to-target approach in the management of juvenile idiopathic arthritis
    Consolaro, A.
    Negro, G.
    Lanni, S.
    Solari, N.
    Martini, A.
    Ravelli, A.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2012, 30 (04) : S157 - S162
  • [46] Implementing treat-to-target urate-lowering therapy during hospitalisations for gout flares: a prospective cohort study
    Russell, Mark D.
    Ameyaw-Kyeremeh, Louise
    Dell Accio, Flora
    Lapham, Heather
    Head, Natalie
    Stovin, Christopher
    Patel, Vishit
    Clarke, Benjamin
    Nagra, Deepak
    Alveyn, Edward
    Adas, Maryam A.
    Bechman, Katie
    de la Puente, Maria A.
    Ellis, Benjamin
    Byrne, Corrine
    Patel, Rina
    Rutherford, Andrew, I
    Cantle, Fleur
    Norton, Sam
    Roddy, Edward
    Hudson, Joanna
    Cope, Andrew P.
    Galloway, James B.
    RHEUMATOLOGY, 2024, 63
  • [47] Assessing Treat To Target In Gout Patients With and Without Tophi
    Harrold, Leslie R.
    Etzel, Carol
    Schechter, Bruce
    Malamet, Raymond L.
    Cox, Vanessa
    Greenberg, Jeffrey D.
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S857 - S857
  • [48] Treat-to-Target Approach in the Management of Elderly Rheumatoid Arthritis Patients
    Joseph, Vivek
    Vontela, Swetha
    Dheer, Surjeet
    Weinberg, Molly
    Haq, Zuhayr
    Jayatilleke, Arundathi
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [49] One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study
    Till Uhlig
    Lars F. Karoliussen
    Joe Sexton
    Tore K. Kvien
    Espen A. Haavardsholm
    Fernando Perez-Ruiz
    Hilde Berner Hammer
    Arthritis Research & Therapy, 24
  • [50] One- and 2-year flare rates after treat-to-target and tight-control therapy of gout: results from the NOR-Gout study
    Uhlig, Till
    Karoliussen, Lars F.
    Sexton, Joe
    Kvien, Tore K.
    Haavardsholm, Espen A.
    Perez-Ruiz, Fernando
    Hammer, Hilde Berner
    ARTHRITIS RESEARCH & THERAPY, 2022, 24 (01)
12345